PAREXEL International Corp (NASDAQ:PRXL)
The Company provides a range of expertise in clinical research, medical communications services, consulting, and informatics and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
SnowBawl
(< 20)
Submitted: 5/20/2013 10:28:13 AM :
Start Price:
$46.75
PRXL Score:
-0.84
Zacks and Fidelity top ranks. 1of 4.
Recs
CellBlock9
(96.30)
Submitted: 5/6/2013 1:25:13 PM :
Start Price:
$44.04
PRXL Score:
+2.00
s&p 5 star
Recs
reddingrunner
(94.03)
Submitted: 5/3/2013 11:54:49 AM :
Start Price:
$44.29
PRXL Score:
+1.25
might be a little rich at EV/EBITDA of 13 but I like it's long term prospects.
Recs
stemcells2011
(38.39)
Submitted: 4/21/2013 4:44:02 PM :
Start Price:
$39.86
PRXL Score:
+9.02
More to this run
Recs
RandomStockPicks
(30.57)
Submitted: 4/17/2013 1:31:21 AM :
Start Price:
$39.56
PRXL Score:
+10.25
Can a random number generator (www.random.org) produce the best 100 stock picks that will beat the market over the years? Let’s find out. :)
My process, for those interested:
I use www.random.org number generator to produce a number between 1 and 7,801. There are 7,801 stocks available to choose on the Motley Fool CAPS Game. Once I get a number, I go to the list, find that stock, and select that stock to outperform for the next five years.
Recs
eat251heart
(42.53)
Submitted: 4/4/2013 11:31:06 AM :
Start Price:
$39.67
PRXL Score:
+9.50
Healthcare is a growing market and concern.Specializing in clinical research and communications are a winner in my book.
Recs
FlyingTiger51
(< 20)
Submitted: 6/1/2012 6:53:56 PM :
Start Price:
$25.55
PRXL Score:
-51.28
Net profit margin comparing to PRXL's competitiors i.e. Quintile, Covance, and PPDI historically has been at least 10 points below. PRXL's cut throat management style to improve short term profitability can only cause more valuable employees and contirbutors deaprting the company.
Recs
KimLanners
(< 20)
Submitted: 5/3/2011 4:16:30 PM :
Start Price:
$23.00
PRXL Score:
+78.39
medical with upside
Recs
Gemini846
(88.73)
Submitted: 8/30/2010 8:14:22 AM :
Start Price:
$21.12
PRXL Score:
+62.74
It's never too early to go Christmas shopping. Picking a broad basket of stocks that seem favorable when expecting a short term bull rally.
Recs
CroMagnon1948
(< 20)
Submitted: 1/15/2010 11:46:09 AM :
Start Price:
$17.54
PRXL Score:
+117.24
Another sell-off buying opportunity.
Recs
hondo928
(99.63)
Submitted: 3/10/2009 4:18:16 PM :
Start Price:
$8.81
PRXL Score:
+331.32
Because I can bet the sector will win, without the risk of crappy management....Pfizer *cough cough*
Recs
PennyStockFool
(30.59)
Submitted: 1/27/2009 4:05:42 PM :
Start Price:
$9.67
PRXL Score:
-282.62
Taking today's (1/27) 30% gain on this stock and going Thumbs Down for a few weeks.
Recs
GKuhfeldt
(53.59)
Submitted: 1/27/2009 3:58:59 PM :
Start Price:
$9.58
PRXL Score:
+282.77
So cheap.
Recs
BobLangley
(86.86)
Submitted: 10/20/2008 11:22:03 PM :
Start Price:
$21.52
PRXL Score:
+38.65
Considerable backlog exists for the services of this clinical research and marketing company whose stock has taken an unjustified hit of late.
Recs
JP1031
(30.58)
Submitted: 10/10/2008 5:02:52 PM :
Start Price:
$22.90
PRXL Score:
+20.95
This stock has consistently outperformed the S&P 500 and seems to be undervalued due to the recent sell off. No debt makes them very attractive in this market.
Recs
suhsido1
(< 20)
Submitted: 9/9/2008 4:58:29 AM :
Start Price:
$31.14
PRXL Score:
+13.19
Clinical research. 4 star.
Recs
ivoirien
(< 20)
Submitted: 7/16/2008 9:35:59 PM :
Start Price:
$27.24
PRXL Score:
+32.45
Breakout today from cup-with-handle, right at confluence of 50-day and 200-day MAs
Recs
Sqwii
(< 20)
Submitted: 6/27/2008 12:46:48 PM :
Start Price:
$26.50
PRXL Score:
+40.13
Biggest gainer in equity potential rank
Recs
Salamatgod
(< 20)
Submitted: 5/16/2008 4:03:21 PM :
Start Price:
$24.49
PRXL Score:
+67.95
it will keep growing
Recs
weezus77
(59.84)
Submitted: 3/13/2008 1:31:00 PM :
Start Price:
$26.58
PRXL Score:
+42.28
This stock is set to split in the middle of March. With $1 billion in sales, and anticipated earnings of almost 30% for both this year and next, PRXL will be a great investment.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 29 : 1 2 Next »